Table 1. Catalyzed by CYPs reactions of drug metabolism resulting in hydroxyl group formation in aromatic rings.
Reactions of aromatic hydroxylation |
|||||
CYP isoform |
Drug |
Anatomical Therapeutic Chemical (ATC) Classification |
Reaction* |
Metabolites |
Reference |
CYP1A2 |
Melatonin |
N05CH – Melatonin receptor agonists |
6-hydroxylation |
6-hydroxymelatonin |
[5] |
Mianserin |
N06AX – Other antidepressants |
8-hydroxylation |
8-hydroxymianserin |
[6] |
|
Estradiol |
G03CA – Natural and semisynthetic estrogens, plain |
2-hydroxylation |
2-hydroxyestradiol |
[7] |
|
CYP2A6 |
Efavirenz |
J05AG – Non-nucleoside reverse transcriptase inhibitors |
7-hydroxylation |
7-hydroxyefavirenz |
[8] |
CYP2B6 |
Mianserin |
N06AX – Other antidepressants |
8-hydroxylation |
8-hydroxymianserin |
[6] |
Propofol |
N01AX – Other general anesthetics |
4-hydroxylation |
4-hydroxypropofol |
[9] |
|
Efavirenz |
J05AG – Non-nucleoside reverse transcriptase inhibitors |
8-hydroxylation |
8-hydroxyefavirenz |
[8] |
|
CYP2C8 |
Rosiglitazone |
A10BG – Thiazolidinediones |
para-hydroxylation |
para-hydroxyrosiglitazone |
[10] |
CYP2C9 |
Acenocoumarol |
B01AA – Vitamin K antagonists |
6- and 7-hydroxylation |
6- or 7-hydroxyacenocoumarol |
[11] |
Diclofenac |
S01BC – Antiinflammatory agents, non-steroids |
4'-hydroxylation |
4'-hydroxydiclofenac |
[12] |
|
Lornoxicam |
M01AC – Oxicams |
5'-hydroxylation |
5'-hydroxylornoxicam |
[13] |
|
Piroxicam |
M01AC – Oxicams |
5'-hydroxylation |
5'-hydroxypiroxicam |
[14] |
|
Phenytoin |
N03AB – Hydantoin derivatives |
4-hydroxylation |
4-hydroxyphenytoin |
[15] |
|
Flurbiprofen |
S01BC – Antiinflammatory agents, non-steroids |
4'-hydroxylation |
4'-hydroxyflurbiprofen |
[16] |
|
(S)-warfarin |
B01AA – Vitamin K antagonists |
7-hydroxylation |
(S)-7-hydroxywarfarin |
[17] |
|
CYP2C19 |
Lansoprazole |
A02BC – Proton pump inhibitors |
5-hydroxylation |
5-hydroxylansoprazole |
[18] |
Phenytoin |
N03AB – Hydantoin derivatives |
4-hydroxylation |
4-hydroxyphenytoin |
[15] |
|
(R)-warfarin |
B01AA – Vitamin K antagonists |
8-hydroxylation |
(R)-8-hydroxywarfarin |
[19] |
|
(S)-mephenytoin |
N03AB – Hydantoin derivatives |
4'-hydroxylation |
(S)-4'-hydroxymephenytoin |
[20] |
|
CYP2D6 |
Aprindine |
C01BB – Antiarrhythmics, class Ib |
5-hydroxylation |
5-hydroxyaprindine |
[21] |
Atomoxetine |
N06BA – Centrally acting sympathomimetics |
4-hydroxylation |
4-hydroxyatomoxetine |
[22] |
|
Desipramine |
N06AA – Non-selective monoamine reuptake inhibitors |
2-hydroxylation |
2-hydroxydesipramine |
[23] |
|
Duloxetine |
N06AX – Other antidepressants |
4-, 5- and 6-hydroxylation |
4-, 5- or 6-hydroxyduloxetine |
[24] |
|
Imipramine |
N06AA – Non-selective monoamine reuptake inhibitors |
2-hydroxylation |
2-hydroxyimipramine |
[23] |
|
Carvedilol |
C07AG – Alpha and beta blocking agents |
4'- and 5'-hydroxylation |
4'- or 5'-hydroxycarvedilol |
[25] |
|
Quetiapine |
N05AH – Diazepines, oxazepines, thiazepines and oxepines |
7-hydroxylation |
7-hydroxyquetiapine |
[26] |
|
Mianserin |
N06AX – Other antidepressants |
8-hydroxylation |
8-hydroxymianserin |
[27] |
|
Mirtazapine |
N06AX – Other antidepressants |
8-hydroxylation |
8-hydroxymirtazapine |
[28] |
|
Promethazine |
R06AD – Phenothiazine derivatives |
7-hydroxylation |
7-hydroxypromethazine |
[29] |
|
Propafenone |
C01BC – Antiarrhythmics, class Ic |
5-hydroxylation |
5-hydroxypropafenone |
[30] |
|
Propranolol |
C07AA – Beta blocking agents, non-selective |
4'- and 5'-hydroxylation |
4'- or 5'-hydroxypropranolol |
[31] |
|
Tamoxifen |
L02BA – Anti-estrogens |
4-hydroxylation |
4-hydroxytamoxifen |
[32] |
|
Chlorpromazine |
N05AA – Phenothiazines with aliphatic side-chain |
7-hydroxylation |
7-hydroxychlorpromazine |
[33] |
|
(E)-clomifene |
G03GB – Ovulation stimulants, synthetic |
4-hydroxylation |
4-hydroxyclomifene |
[34] |
|
CYP2E1 |
Chlorzoxazone |
M03BB – Oxazol, thiazine, and triazine derivatives |
6-hydroxylation |
6-hydroxychlorzoxazone |
[35] |
CYP3A4/3A5 |
Atorvastatin |
C10AA – HMG CoA reductase inhibitors |
Para- and ortho-hydroxylation |
Para- or ortho-hydroxyatorvastatin |
[36] |
Diclofenac |
S01BC – Antiinflammatory agents, non-steroids |
5-hydroxylation |
5-hydroxydiclofenac |
[37] |
|
Quetiapine |
N05AH – Diazepines, oxazepines, thiazepines and oxepines |
7-hydroxylation |
7-hydroxyquetiapine |
[26] |
|
Mianserin |
N06AX – Other antidepressants |
8-hydroxylation |
8-hydroxymianserin |
[6] |
|
Nevirapine |
J05AG – Non-nucleoside reverse transcriptase inhibitors |
2-hydroxylation |
2-hydroxynevirapine |
[38] |
|
Trazodone |
N06AX – Other antidepressants |
4'-hydroxylation |
4'-hydroxytrazodone |
[39] |
|
Ethinylestradiol |
L02AA – Estrogens |
2-hydroxylation |
2-hydroxythinylestradiol |
[40] |
|
Delakylation reactions |
|||||
CYP1A2 |
Melatonin |
N05CH – Melatonin receptor agonists |
O-demethylation |
N-acetylserotonin |
[5] |
Mianserin |
N06AX – Other antidepressants |
N-demethylation |
N-desmethylmianserin |
[6] |
|
Naproxen |
S01BC – Antiinflammatory agents, non-steroids |
O-demethylation |
O-desmethylnaproxen |
[41] |
|
Phenacetin |
N02BE – Anilides |
O-deethylation |
O-deethylphenacetin (Acetaminophen, paracetamol) |
[42] |
|
CYP2C9 |
Indomethacin |
S01BC – Antiinflammatory agents, non-steroids |
O-demethylation |
О-desmethylindomethacin |
[43] |
Carvedilol |
C07AG – Alpha and beta blocking agents |
O-demethylation |
O-desmethylcarvedilol |
[44] |
|
CYP2C19 |
Melatonin |
N05CH – Melatonin receptor agonists |
O-demethylation |
N-acetylserotonin |
[5] |
CYP2D6 |
Venlafaxine |
N06AX – Other antidepressants |
O-demethylation |
О-desmethylvenlafaxine |
[45] |
Galantamine |
N06DA – Anticholinesterases |
O-demethylation |
O-desmethylgalantamine |
[46] |
|
Gefitinib |
L01XE – Protein kinase inhibitors |
O-demethylation |
O-desmethylgefitinib |
[47] |
|
Hydrocodone |
R05DA – Opium alkaloids and derivatives |
O-demethylation |
O-desmethylhydrocodone |
[48] |
|
Dextromethorphan |
R05DA – Opium alkaloids and derivatives |
O-demethylation |
Dextrorphan |
[49] |
|
Dihydrocodeine |
N02AA – Natural opium alkaloids |
O-demethylation |
Dihydromorphine |
[50] |
|
Codeine |
R05DA – Opium alkaloids and derivatives |
O-demethylation |
Morphine |
[51] |
|
Oxycodone |
N02AA – Natural opium alkaloids |
O-demethylation |
O-desmethyloxycodone |
[52] |
|
Tramadol |
N02AX – Other opioids |
O-demethylation |
O-desmethyltramadol |
[53] |
|
Flecainide |
C01BC – Antiarrhythmics, class Ic |
meta-O-dealkylation |
meta-O-dealkylated flecainide |
[54] |
|
CYP2J2 |
Astemizole |
R06AX — Other antihistamines for systemic use |
O-demethylation |
O-desmethylastemizole |
[55] |
CYP3A4/3A5 |
Donepezil |
N06DA – Anticholinesterases |
O-demethylation |
O-desmethyldonepezil |
[56] |
Note. *These reactions can be the main path or one of the possible paths of the metabolism of the listed drugs